Financhill
Back

Cellectis SA Stock Predictions

Sell
37

CLLS
Cellectis SA

Last Price:
2.71
Seasonality Move:
-11.61%

7 Day Trial

ALL ACCESS PASS

$ 7

Cellectis SA Stock Forecast

  • Is Cellectis SA Stock Undervalued?
    The current Cellectis SA [CLLS] share price is $2.72. The Score for CLLS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • CLLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Cellectis SA Stock Go Up Next Year?

Data Unavailable

Cellectis SA Stock Rating

Data Unavailable

Cellectis SA Stock Price History

Is CLLS stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLLS is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
France
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cellectis.com

52-Week Data

52-Week High:
3.77
52-Week Low:
0.96

Prediction Charts

Market Cap:
271.88M
Price in USD:
2.72
Volume:
13.21K
Beta:
2.77

Technical Analysis

SMA50:
2.76
SMA100:
2.76
SMA200:
2.49
52-Wk Change:
43.16%

Stock Predictions

  • Is Cellectis SA stock public?
    Yes, Cellectis SA is a publicly traded company.
  • What is the Cellectis SA stock quote today?
    The Cellectis SA stock price is 2.72 USD today.
  • How to buy Cellectis SA stock online?
    You can buy Cellectis SA shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-13 3.03 2.97 3.04 2.95
May-14 2.97 3.04 3.07 2.96
May-15 3.10 3.06 3.10 2.97
May-16 3.04 3.04 3.04 2.96
May-17 2.99 2.99 3.00 2.87
May-20 2.96 2.97 3.00 2.94
May-21 2.92 2.95 2.96 2.81
May-22 2.90 2.92 2.92 2.88
May-23 2.89 2.90 2.95 2.82
May-24 2.86 2.82 2.91 2.74
May-28 2.72 2.78 2.80 2.69
May-29 2.56 2.70 2.75 2.56
May-30 2.69 2.71 2.73 2.69
May-31 2.71 2.72 2.81 2.63

Cellectis SA Earnings

Data Unavailable

Cellectis SA Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.47 per share, and a decrease next year of $0.53 per share.

* Cellectis SA stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.